NCT04917809 2026-04-22
A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
Memorial Sloan Kettering Cancer Center
White River Junction Veterans Affairs Medical Center
University of Iowa
Tyra Biosciences, Inc
Hoosier Cancer Research Network
Merck Sharp & Dohme LLC